Risk factors for cardiovascular disease: does a role for homocysteine still exist?

被引：6

作者：

Bendini, Maria Grazia ^{[1
]}

Lanza, Gaetano Antonio ^{[2
]}

Mazza, Andrea ^{[1
]}

Giordano, Andrea ^{[3
]}

Leggio, Massimo ^{[4
]}

Menichini, Giulio ^{[5
]}

De Cristofaro, Raffaele ^{[1
]}

Moriconi, Emanuela ^{[5
]}

Cozzari, Laura ^{[1
]}

Farina, Sergio Maria ^{[1
]}

Giordano, Giampiero ^{[1
]}

机构：

[1] Osped S Maria della Stella, UO Cardiol, Orvieto, TR, Italy

[2] Univ Cattolica Sacro Cuore, Ist Cardiol, Rome, Italy

[3] Osped S Maria della Stella, UO Nefrol, Orvieto, TR, Italy

[4] Osped San Filippo Neri, UO Riabilitaz Cardiovasc, Rome, Italy

[5] Osped S Maria della Stella, Med & Chirurg Accettaz & Urgenza, Orvieto, TR, Italy

来源：

GIORNALE ITALIANO DI CARDIOLOGIA | 2007年 / 8卷 / 03期

关键词：

Atherosclerosis; Cardiovascular diseases; Homocysteine; Vitamins;

D O I：

10.1714/678.7897

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Cardiovascular diseases are commonly related to classical risk factors, but other risk markers have been identified, including homocysteine. Homocysteine is a sulphurated amino acid which derives from methionine. The causes of hyperhomocysteinemia are multifactorial, such as genetic defects, pathophysiological conditions, lifestyle and drugs-related. Hyperhomocysteinemia favors atherothrombosis through endothelial dysfunction, enhancement of inflammation and thrombophilic profile. A number of clinical and laboratory trials exist regarding the association between homocysteine levels and an increased risk of cardiovascular disease. However, the lack of homogeneity in the data, together with the high number of factors capable of influencing homocysteine plasma levels, and the disappointing results of therapeutic trials do not permit us at present to consider homocysteine as an independent and major risk factor for cardiovascular disease.

引用

页码：148 / 160

页数：13

共 50 条

[1] Homocysteine - is it still an important risk factor for cardiovascular disease?
Cybulska, Barbara
Klosiewicz-Latoszek, Longina
KARDIOLOGIA POLSKA, 2015, 73 (11) : 1092 - 1096
[2] Homocysteine and ADMA - emerging risk factors for cardiovascular disease?
Hedner, T
Himmelmann, A
Hansson, L
BLOOD PRESSURE, 2002, 11 (04) : 197 - 200
[3] Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about it?
Faeh, David
Chiolero, Arnaud
Paccaud, Fred
SWISS MEDICAL WEEKLY, 2006, 136 (47-48) : 745 - 756
[4] Homocysteine and risk of cardiovascular disease
Andreotti, F
Burzotta, F
Manzoli, A
Robinson, K
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2000, 9 (01) : 13 - 21
[5] Homocysteine and Risk of Cardiovascular Disease
Felicita Andreotti
Francesco Burzotta
Alessandro Manzoli
Killian Robinson
Journal of Thrombosis and Thrombolysis, 2000, 9 : 13 - 21
[6] Homocysteine and cardiovascular risk factors in epilepsy
Jacobson, KP
Elliott, JO
EPILEPSIA, 2005, 46 : 345 - 345
[7] Cardiovascular risk factors and homocysteine in epilepsy
Haneef, Zulfi
Jacobson, Mercedes P.
Elliott, John O.
NEUROLOGY, 2007, 68 (12) : A149 - A149
[8] Homocysteine as a risk factor for cardiovascular disease
Graham, IM
Meleady, R
ATHEROSCLEROSIS XI, 1998, 1155 : 419 - 423
[9] Homocysteine and Reclassification of Cardiovascular Disease Risk
Veeranna, Vikas
Zalawadiya, Sandip K.
Niraj, Ashutosh
Pradhan, Jyotiranjan
Ference, Brian
Burack, Robert C.
Jacob, Sony
Afonso, Luis
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (10) : 1025 - 1033
[10] Homocysteine as a risk factor in cardiovascular disease
Cole, DEC
DIABETES AND CARDIOVASCULAR DISEASE: ETIOLOGY, TREATMENT, AND OUTCOMES, 2001, 498 : 59 - 64

← 1 2 3 4 5 →